Impax Asset Management Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.06M | Sell |
4,622
-2,377
| -34% | -$1.06M | 0.01% | 230 |
|
|
2025
Q1 | $3.39M | Buy |
6,999
+75
| +1% | +$36.4K | 0.02% | 221 |
|
|
2024
Q4 | $2.79M | Sell |
6,924
-509
| -7% | -$205K | 0.01% | 238 |
|
|
2024
Q3 | $3.46M | Sell |
7,433
-45,963
| -86% | -$21.4M | 0.01% | 234 |
|
|
2024
Q2 | $25M | Sell |
53,396
-14,362
| -21% | -$6.73M | 0.1% | 116 |
|
|
2024
Q1 | $28.3M | Sell |
67,758
-16,555
| -20% | -$6.92M | 0.11% | 122 |
|
|
2023
Q4 | $34.3M | Sell |
84,313
-473,825
| -85% | -$193M | 0.14% | 114 |
|
|
2023
Q3 | $194M | Sell |
558,138
-25,782
| -4% | -$8.95M | 0.87% | 39 |
|
|
2023
Q2 | $205M | Sell |
583,920
-178,427
| -23% | -$62.7M | 0.82% | 43 |
|
|
2023
Q1 | $240M | Sell |
762,347
-1,664
| -0.2% | -$523K | 1% | 35 |
|
|
2022
Q4 | $220M | Buy |
764,011
+66,278
| +9% | +$19.1M | 0.99% | 37 |
|
|
2022
Q3 | $202M | Sell |
697,733
-23,201
| -3% | -$6.71M | 1.04% | 33 |
|
|
2022
Q2 | $203M | Sell |
720,934
-139,738
| -16% | -$39.4M | 0.99% | 35 |
|
|
2022
Q1 | $225M | Sell |
860,672
-172,183
| -17% | -$44.9M | 0.93% | 39 |
|
|
2021
Q4 | $227M | Sell |
1,032,855
-41,881
| -4% | -$9.2M | 0.83% | 47 |
|
|
2021
Q3 | $195M | Buy |
1,074,736
+319,209
| +42% | +$57.9M | 0.8% | 49 |
|
|
2021
Q2 | $152M | Buy |
755,527
+666,559
| +749% | +$134M | 0.67% | 55 |
|
|
2021
Q1 | $19.1M | Buy |
88,968
+13,396
| +18% | +$2.88M | 0.1% | 109 |
|
|
2020
Q4 | $17.9M | Buy |
75,572
+10,381
| +16% | +$2.45M | 0.11% | 100 |
|
|
2020
Q3 | $17.7M | Buy |
65,191
+18,641
| +40% | +$5.07M | 0.16% | 91 |
|
|
2020
Q2 | $13.5M | Sell |
46,550
-6,121
| -12% | -$1.78M | 0.14% | 102 |
|
|
2020
Q1 | $12.5M | Buy |
52,671
+7,880
| +18% | +$1.88M | 0.17% | 101 |
|
|
2019
Q4 | $9.81M | Buy |
44,791
+468
| +1% | +$102K | 0.11% | 117 |
|
|
2019
Q3 | $7.51M | Buy |
44,323
+39,709
| +861% | +$6.73M | 0.1% | 137 |
|
|
2019
Q2 | $846K | Buy |
4,614
+444
| +11% | +$81.4K | 0.01% | 204 |
|
|
2019
Q1 | $767K | Buy |
4,170
+703
| +20% | +$129K | 0.01% | 235 |
|
|
2018
Q4 | $575K | Buy |
3,467
+66
| +2% | +$10.9K | 0.01% | 222 |
|
|
2018
Q3 | $656K | Buy |
+3,401
| New | +$656K | 0.01% | 230 |
|